Your browser doesn't support javascript.
loading
Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B Neisseria meningitidis Strains and Their Predicted Coverage by the 4CMenB Vaccine.
Tsang, Raymond S W; Law, Dennis K S; De Paola, Rosita; Giuliani, Maria; Stella, Maria; Zhou, Jianwei; Deng, Saul; Boccadifuoco, Giuseppe; Giuliani, Marzia Monica; Serino, Laura.
Affiliation
  • Tsang RSW; Vaccine Preventable Bacterial Diseases, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada raymond.tsang@canada.ca.
  • Law DKS; Vaccine Preventable Bacterial Diseases, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • De Paola R; GSK, Siena, Italy.
  • Giuliani M; GSK, Siena, Italy.
  • Stella M; GSK, Siena, Italy.
  • Zhou J; Vaccine Preventable Bacterial Diseases, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Deng S; Vaccine Preventable Bacterial Diseases, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Boccadifuoco G; GSK, Siena, Italy.
  • Giuliani MM; GSK, Siena, Italy.
  • Serino L; GSK, Siena, Italy.
mSphere ; 5(2)2020 03 04.
Article in En | MEDLINE | ID: mdl-32132156
The molecular epidemiology of culture-confirmed invasive meningococcal disease (IMD) in Canada from 2010 to 2014 was studied with an emphasis on serogroup B Neisseria meningitidis (MenB) isolates, including their predicted coverage by the 4CMenB vaccine. The mean annual incidence rates of culture confirmed IMD varied from 0.19/100,000 in Ontario to 0.50/100,000 in New Brunswick and 0.59/100,000 in Quebec. In both Quebec and Atlantic region, MenB was significantly more common than other serogroups, while in other provinces, both MenB and serogroup Y (MenY) were almost equally common. The majority of MenB cases (67.0%) were in those aged ≤24 years, while most MenC (75.0%) and MenY (69.6%) cases were in adults more than 24 years old. The 349 MenB isolates were grouped into 103 sequence types (STs), 90 of which belonged to 13 clonal complexes (CCs). A large number of 4CMenB antigen genes were found among the Canadian MenB, which is predicted to encode 50 factor H binding protein (fHbp) types, 40 NHBA types, and 55 PorA genotypes. Provinces and regions were found to have their own unique MenB STs. A meningococcal antigen typing system assay predicted an overall MenB coverage by 4CMenB to be 73.6%, with higher coverage predicted for the two most common STs: 100% for ST154 and 95.9% for ST269, leading to higher coverage in both the Atlantic region and Quebec. Higher coverage (81.4%) was also found for MenB recovered from persons aged 15 to 24 years, followed by strains from infants and children ≤4 years old (75.2%) and those aged 5 to 14 years (75.0%).IMPORTANCE Laboratory surveillance of invasive meningococcal disease (IMD) is important to our understanding of the evolving nature of the Neisseria meningitidis strain types causing the disease and the potential coverage of disease strains by the newly developed vaccines. This study examined the molecular epidemiology of culture-confirmed IMD cases in Canada by examining the strain types and the potential coverage of a newly licensed 4CMenB vaccine on Canadian serogroup B N. meningitidis strains. The strain types identified in different parts of Canada appeared to be unique as well as their predicted coverage by the 4CMenB vaccine. These data were compared to data obtained from previous studies done in Canada and elsewhere globally. For effective control of IMD, laboratory surveillance of this type was found to be essential and useful to understand the dynamic nature of this disease.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Variation / Meningococcal Vaccines / Neisseria meningitidis, Serogroup B / Meningococcal Infections Type of study: Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adolescent / Adult / Aged / Child / Child, preschool / Humans / Infant / Middle aged Country/Region as subject: America do norte Language: En Journal: MSphere Year: 2020 Document type: Article Affiliation country: Canada Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Variation / Meningococcal Vaccines / Neisseria meningitidis, Serogroup B / Meningococcal Infections Type of study: Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adolescent / Adult / Aged / Child / Child, preschool / Humans / Infant / Middle aged Country/Region as subject: America do norte Language: En Journal: MSphere Year: 2020 Document type: Article Affiliation country: Canada Country of publication: United States